Elanco is closely monitoring the situation on the spread of Coronavirus (COVID-19) from both a local and global perspective. Our primary focus is to our teams, our supply to our customers and keeping you informed. We have had questions about supply of product. Elanco benefits from a global manufacturing and supply network to source its ingredients and medicines plus there are managed stocks of medicines held in the UK and in other distribution hubs.
Locally we are taking all actions to ensure we comply with official guidance and instructions, to protect our teams and customers.
With the renewed advice to reduce contact, we have decided that our office workers should continue to work from home where possible. If there is a need to work in the office, we will continue to follow the guidance offered by the Government including social distancing, face coverings and hand cleaning.
Our field teams are permitted to travel and visit any customers that prefer a face-to-face meeting as long as everyone feels comfortable and that all appropriate C-19 controls are in place. We will be monitoring government guidance and reviewing our processes on an ongoing basis.
Elanco will update this information as we continue to monitor the situation and we wish to reassure customers that currently there is no impact of coronavirus on the supply of Elanco products to the United Kingdom and Ireland.
Watch Jeff Simmons discuss the pandemic and the Elanco promise to our customers here.